Chargement en cours...
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis
As of today, 20 disease-modifying drugs (DMDs) have been approved for the treatment of relapsing multiple sclerosis (MS) and, based on their efficacy, they can be grouped into moderate-efficacy DMDs and high-efficacy DMDs. The choice of the drug mostly relies on the judgment and experience of neurol...
Enregistré dans:
| Publié dans: | Cells |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7140535/ https://ncbi.nlm.nih.gov/pubmed/32121606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9030586 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|